Refractive Error

Approaches for the detection and treatment of amblyopia have improved in the past 3 decades, but there is still room for improvement, according to a presenter at the virtual American Academy of Ophthalmology annual meeting.

Overminus therapy, a method that has been used to control intermittent exotropia, was found to increase myopia progression, particularly in children who are already myopic, according to research presented at the American Academy of Optometry virtual meeting.

Most optometrists report proactive use of cycloplegia but may still wish to have more evidence-based resources on which to base their decisions, according to a study in Ophthalmic and Physiological Optics.

MiSight daily disposable soft contact lenses were effective at slowing myopia progression compared with standard daily disposable lenses, according to study results published in Journal Optometry and Vision Science.

When a patient presents with abnormal eye movements and complaints of dizziness, vision therapy might be the answer, but jumping to that conclusion right away would be a mistake.

In recent years, there has been a clear trend toward lens-based rather than cornea-based refractive surgery for moderate to high hyperopes. This is due in part to recognition of the limitations of corneal optics in hyperopic LASIK and the increased chance of hyperopic regression.

by Christina Twardowski, OD, FAAO

You may have seen my article in April 2019 discussing how I manage myopia in my practice. Myopia is a serious global health concern. Today, well over 1 billion people around the world are struggling with the condition. This number is only expected to increase in the future, especially among school-age children, reaching nearly 5 billion by 2050. In the U.S. alone, over 40% of Americans are nearsighted, according to the Brien Holden Vision Institute.

Patients who underwent cataract surgery showed increased anterior chamber depth postoperatively, which correlated with refractive error.

The first patient has been implanted in an investigational clinical study of STAAR Surgical’s EVO ICL family of lenses, according to a press release.